Omni Star Financial Group, Inc. Eli Lilly & CO Transaction History

Omni Star Financial Group, Inc.

$105 Million
Q2 2024

A detailed history of Omni Star Financial Group, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Omni Star Financial Group, Inc. holds 266 shares of LLY stock, worth $237,024. This represents 0.23% of its overall portfolio holdings.

Number of Shares

266

Previous 265 0.38%

Holding current value

$237,024

Previous $206,000 16.5%

% of portfolio

0.23%

Previous 0.2%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 26, 2024	BUY	$724.87 - $909.04 $724 - $909	1 Added 0.38%	266 $240,000
Q1 2024 Apr 22, 2024	BUY	$592.2 - $792.28 $156,933 - $209,954	265 New	265 $206,000
Q4 2022 Jan 20, 2023	SELL	$321.55 - $374.67 $278,462 - $324,464	-866 Reduced 57.31%	645 $0
Q3 2022 Nov 14, 2022	SELL	$296.48 - $337.87 $96,356 - $109,807	-325 Reduced 17.7%	1,511 $488,000
Q2 2022 Aug 03, 2022	SELL	$278.73 - $327.27 $25,085 - $29,454	-90 Reduced 4.67%	1,836 $595,000
Q1 2022 May 05, 2022	SELL	$234.69 - $291.66 $140,814 - $174,996	-600 Reduced 23.75%	1,926 $551,000
Q4 2021 Feb 11, 2022	BUY	$224.85 - $279.04 $545,486 - $676,951	2,426 Added 2426.0%	2,526 $697,000
Q3 2021 Nov 12, 2021	SELL	$221.6 - $272.71 $853,381 - $1.05 Million	-3,851 Reduced 97.47%	100 $573,000
Q1 2021 May 13, 2021	SELL	$164.32 - $212.72 $310,071 - $401,402	-1,887 Reduced 32.32%	3,951 $738,000
Q4 2020 Feb 09, 2021	BUY	$130.46 - $172.63 $164,770 - $218,031	1,263 Added 27.61%	5,838 $986,000
Q3 2020 Oct 22, 2020	SELL	$146.22 - $169.13 $74,864 - $86,594	-512 Reduced 10.06%	4,575 $677,000
Q2 2020 Jul 06, 2020	SELL	$136.42 - $164.18 $65,754 - $79,134	-482 Reduced 8.66%	5,087 $835,000
Q1 2020 Apr 27, 2020	SELL	$119.05 - $147.35 $294,529 - $364,543	-2,474 Reduced 30.76%	5,569 $773,000
Q4 2019 Jan 13, 2020	BUY	$106.92 - $132.43 $257,142 - $318,494	2,405 Added 42.66%	8,043 $1.06 Million
Q3 2019 Oct 11, 2019	BUY	$106.79 - $116.16 $55,317 - $60,170	518 Added 10.12%	5,638 $631,000
Q2 2019 Jul 30, 2019	SELL	$110.79 - $129.32 $44,316 - $51,728	-400 Reduced 7.25%	5,120 $567,000
Q1 2019 Apr 12, 2019	SELL	$111.31 - $131.02 $1.51 Million - $1.77 Million	-13,525 Reduced 71.02%	5,520 $716,000
Q4 2018 Feb 12, 2019	SELL	$105.9 - $118.64 $1.69 Million - $1.89 Million	-15,912 Reduced 45.52%	19,045 $2.2 Million
Q3 2018 Nov 16, 2018	SELL	$85.86 - $107.31 $55,379 - $69,214	-645 Reduced 1.81%	34,957 $3.75 Million
Q2 2018 Aug 14, 2018	BUY	$75.7 - $86.88 $1.07 Million - $1.22 Million	14,070 Added 65.34%	35,602 $3.04 Million
Q1 2018 May 11, 2018	BUY	$74.21 - $87.6 $42,819 - $50,545	577 Added 2.75%	21,532 $1.67 Million
Q4 2017 Mar 13, 2018	BUY	$81.94 - $87.89 $1.72 Million - $1.84 Million	20,955	20,955 $1.77 Million

Others Institutions Holding LLY

# of Institutions

3,869

Shares Held

751M

Call Options Held

6.34M

Put Options Held

7.97M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $847B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Omni Star Financial Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Omni Star Financial Group, Inc. with notifications on news.

Account

Omni Star Financial Group, Inc. Eli Lilly & CO Transaction History